Home/Filings/4/0001144204-13-006558
4//SEC Filing

Greenwell James J 4

Accession 0001144204-13-006558

CIK 0001415684other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 6:16 PM ET

Size

6.5 KB

Accession

0001144204-13-006558

Insider Transaction Report

Form 4
Period: 2013-02-04
Transactions
  • Purchase

    Series D Convertible Preferred Stock

    2013-02-04$8.00/sh+2,500$20,0002,500 total
    From: 2013-02-04Common Stock (5,000 underlying)
Holdings
  • Common Stock

    353
Footnotes (3)
  • [F1]Each share of Series D Convertible Preferred Stock is convertible into two shares of Common Stock (the "Conversion Rate"). The Conversion Rate is subject to adjustment upon the occurrence of certain events, such as stock splits or the issuance by the Issuer of Common Stock at a price per of less than $4.00 per share of Common Stock.
  • [F2]Except upon a mandatory conversion event, the Series D Convertible Preferred Stock is convertible at any time, at the Reporting Person's election, and has not expiration date.
  • [F3]On November 26, 2012, the Issuer effected a 1-for-850 reverse stock split of its Common Stock, resulting in the Reporting Person's ownership of 353 shares of Common Stock rather than 300,000 shares of Common Stock.

Issuer

MusclePharm Corp

CIK 0001415684

Entity typeother

Related Parties

1
  • filerCIK 0001561664

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:16 PM ET
Size
6.5 KB